These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 20685398)

  • 41. Pocket extraction on proteins via the Voronoi diagram of spheres.
    Kim D; Cho CH; Cho Y; Ryu J; Bhak J; Kim DS
    J Mol Graph Model; 2008 Apr; 26(7):1104-12. PubMed ID: 18023220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-based drug discovery and protein targets in the CNS.
    Hubbard RE
    Neuropharmacology; 2011 Jan; 60(1):7-23. PubMed ID: 20673774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identifying and characterizing binding sites and assessing druggability.
    Halgren TA
    J Chem Inf Model; 2009 Feb; 49(2):377-89. PubMed ID: 19434839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using novel descriptor accounting for ligand-receptor interactions to define and visually explore biologically relevant chemical space.
    Rabal O; Oyarzabal J
    J Chem Inf Model; 2012 May; 52(5):1086-102. PubMed ID: 22486368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How to avoid rediscovering the known.
    Kuo LC
    Methods Enzymol; 2011; 493():159-68. PubMed ID: 21371591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Designing a new Diels-Alderase: a combinatorial, semirational approach including dynamic optimization.
    Linder M; Johansson AJ; Olsson TS; Liebeschuetz J; Brinck T
    J Chem Inf Model; 2011 Aug; 51(8):1906-17. PubMed ID: 21780795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1.
    Noeske T; Trifanova D; Kauss V; Renner S; Parsons CG; Schneider G; Weil T
    Bioorg Med Chem; 2009 Aug; 17(15):5708-15. PubMed ID: 19574055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selecting chemicals: the emerging utility of DNA-encoded libraries.
    Clark MA
    Curr Opin Chem Biol; 2010 Jun; 14(3):396-403. PubMed ID: 20346729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aroma WaterLOGSY: a fast and sensitive screening tool for drug discovery.
    Hu J; Eriksson PO; Kern G
    Magn Reson Chem; 2010 Dec; 48(12):909-11. PubMed ID: 21038321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting protein druggability.
    Hajduk PJ; Huth JR; Tse C
    Drug Discov Today; 2005 Dec; 10(23-24):1675-82. PubMed ID: 16376828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
    Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
    J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural basis of the drug-binding specificity of human serum albumin.
    Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
    J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The importance of drug-target residence time.
    Zhang R; Monsma F
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):488-96. PubMed ID: 19562645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Off-rate screening (ORS) by surface plasmon resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction products.
    Murray JB; Roughley SD; Matassova N; Brough PA
    J Med Chem; 2014 Apr; 57(7):2845-50. PubMed ID: 24520903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ligand efficiency and fragment-based drug discovery.
    Bembenek SD; Tounge BA; Reynolds CH
    Drug Discov Today; 2009 Mar; 14(5-6):278-83. PubMed ID: 19073276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
    Larsson A; Jansson A; Åberg A; Nordlund P
    Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacophore screening of the protein data bank for specific binding site chemistry.
    Campagna-Slater V; Arrowsmith AG; Zhao Y; Schapira M
    J Chem Inf Model; 2010 Mar; 50(3):358-67. PubMed ID: 20112952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.